NEW YORK (GenomeWeb) – The head of the Senate Health Committee announced late yesterday that the committee will not consider the sweeping House-backed biomedical research funding bill known as the 21st Century Cures Act, but instead will vote on separate narrower bills related to different aspects of the act such as electronic health records and treatments for rare diseases.